Combination therapy improves outcomes for advanced triple-negative breast cancer

Published Date: 22 Aug 2025

A new study led by researchers at the Icahn School of Medicine at Mount Sinai has found that adding the targeted therapy everolimus to standard carboplatin chemotherapy extends the time before disease progression in patients ...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Coffee, Tea Tied to Lower Risk of Head and Neck Cancer

2.

Research Indicates that First-Line Immunotherapy Is Enough for Elderly NSCLC Patients?

3.

COVID-19 mRNA vaccines could unlock the next revolution in cancer treatment

4.

Testosterone recovery linked to overall survival in high-risk prostate cancer

5.

Combination therapy improves outcomes for advanced triple-negative breast cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot